Publicaciones en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (22)

2023

  1. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774

2020

  1. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population

    Open Respiratory Archives, Vol. 2, Núm. 3, pp. 119-126

  2. Home Mechanical Ventilation

    Open Respiratory Archives, Vol. 2, Núm. 2, pp. 67-88

2019

  1. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Determinants of change in physical activity during moderate-to-severe copd exacerbation

    International Journal of COPD, Vol. 11, pp. 251-261

  3. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

  4. One-year Mortality in COPD After an Exacerbation: The Effect of Physical Activity Changes During the Event

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 13, Núm. 6, pp. 718-725

  5. Predictors of Change in Dyspnea Level in Acute Exacerbations of COPD

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 13, Núm. 3, pp. 303-311

2015

  1. A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: A cohort study

    Respiratory Research, Vol. 16, Núm. 1

  2. Predictors of Hospital Length of Stay in Patients with Exacerbations of COPD: A Cohort Study

    Journal of General Internal Medicine, Vol. 30, Núm. 6, pp. 824-831

2014

  1. Obstructive sleep apnea is associated with cancer mortality in younger patients

    Sleep Medicine, Vol. 15, Núm. 7, pp. 742-748

  2. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments

    BMC Medicine, Vol. 12, Núm. 1

  3. Prognostic severity scores for patients with COPD exacerbations attending emergency departments

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 12, pp. 1415-1420

  4. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes

    PLoS ONE, Vol. 9, Núm. 6

2011

  1. Explicit criteria for hospital admission in exacerbations of chronic obstructive pulmonary disease

    International Journal of Tuberculosis and Lung Disease, Vol. 15, Núm. 5, pp. 680-686